Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep439 | Thyroid | ECE2020

Next generation sequencing of 12 gene panel in differentiated thyroid cancer

Bangaraiahgari Ramesh , Bhargav Panchangam Ramakanth , B Chakrapani , Mayilvaganan Sabaretnam , B Rajesh , Md Rafi , G Rakshith , Akshaya Ramesh D Lakshmi

Introduction: Next-generation sequencing (NGS) in thyroid cancer allows for high-throughput sequencing analysis of various genetic alterations and provides a useful information of tumor biology. NGS Studies on follicular differentiated thyroid cancer have been scanty from Indian subcontinent. In this context, we set out study the prevalence of a genetic panel wide somatic mutations in thyroid cancer.Material and Methods: This prospective study was conduc...

ea0070aep948 | Thyroid | ECE2020

Next generation sequencing of 12-gene panel Molecular profiling of Thyroid cancer: An indian study

Bangaraiahgari Ramesh , Bhargav Panchangam Ramakanth , Mayilvaganan Sabaretnam , G Rakshith , B Rajesh , Md Rafi , Akshaya Ramesh D Lakshmi , V Akhila , Shetty M Shiran , T Shreshta , P Sweeya

Introduction: Next-generation sequencing (NGS) in thyroid cancer allows for high-throughput sequencing analysis of various genetic alterations and provides a useful information of tumor biology. NGS Studies on follicular differentiated thyroid cancer have been scantyfrom Indian subcontinent. In this context, we set out study the prevalence of a genetic panel wide somatic mutations in thyroid cancer.Material and Methods: This prospective study was conduct...

ea0070aep950 | Thyroid | ECE2020

Is Poorly diffentiated thyroid cancer a bridge between well differentiated and anaplastic cancer – Genomic perspective

Bhargav Panchangam Ramakanth , Bangaraiahgari Ramesh , Bangaraiahgari Rajesh , Md Rafi , Reddy B Rajkiran , Mayilvaganan Sabaretnam , G Rakshith , Akshaya Ramesh Devanapalli Lakshmi , Vemula Akhila , Shetty M Shiran , T Shreshta , P Sweeya

Introduction: Poorly differentiated thyroid cancer (PDC) is a relatively rare form of differentiated thyroid caner with intermediate prognosis between well differentiated (WDTC) and anaplastic cancers (ATC). But, this finding is debatable in literature. Genomics is the one of definitive modalities to resolve this conundrum. ATC tends to express P53 and KMT2D mutations frequently, while WDTC have no such mutations. Similar studies are scanty in PDC. In this context, we set out ...